Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

Toddler’s seizures stopped after consuming cannabis oil, parents say

Posted by AGORACOM-JC at 10:50 AM on Thursday, May 22nd, 2014

JUSTIN GIOVANNETTI

VANCOUVER — The Globe and Mail

Last updated Tuesday, May. 20 2014, 8:05 PM EDT

Two-year-old Kyla Williams hasn‘t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family say she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp. (handout from family)

Two-year-old Kyla Williams hasn’t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family says she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp.

The oil being used by the toddler has high amounts of cannabidiol, known as CBD, the main ingredient in medical marijuana, and almost no psychoactive ingredients. Its use is in a legal “grey area,” according to proponents.

Only dried marijuana is currently regulated by Health Canada, the sale of resin and oil by growers is forbidden. The hemp that the cannabis oil is being extracted from is supposed to be destroyed by farmers under federal regulations. However, few controls seem to govern the dispensary and parents providing the two-year-old with the oil.

Despite the lack of legal clarity, Kyla is continuing to use her unconventional medicine. On Sunday evening, she had been seizure-free for a week.

“Within 20 minutes of administering it the first time, she stopped her seizures completely. She had six seizures earlier as I said goodbye to her, it was so hard to watch,” said grandmother Elaine Nuessler.

On Saturday, the girl’s grandfather spoke publicly about the need for greater access to the medical marijuana-like substance. A former RCMP officer, Chris Nuessler told a crowd of 60 in Summerland, B.C. that his views on marijuana have changed significantly since his granddaughter began showing signs of uncontrollable epilepsy when she was six months old.

“We come from a background where we’ve never dealt with marijuana before in our lives,” said Ms. Nuessler. “We’ve discovered that it’s a healing plant.”

For more than a year, Kyla was treated with a battery of prescription drugs, none worked, many made her condition worse. Due to the epilepsy, the girl also suffers from serious visual impairments.

After being told by physicians that the girl’s life would be cut short by the seizures, the family contacted Jim Leslie at the Nation’s Best Weeds Society, a dispensary in Vancouver’s east end. Aided by anecdotal evidence that cannabis with high levels of CBD was being used successfully in the United States, Mr. Leslie set out to find something similar in Canada.

He soon came across an often discarded piece of hemp that is high in CBD. “We’ve got a winner here,” he remembers thinking when he saw the results of tests on the plant. “A small, small percentage of farmers are diverting the CBD-rich part of the plants to us,” said Mr. Leslie.

The Vancouver-based dispensary has a note from Kyla’s pediatric physician recommending cannabis. Under federal rules, the family should be providing the two-year-old with medical marijuana in it’s more traditional form.

In the past, Canadians have moved to the U.S. to gain access to the oil. In late 2013, the parents of 13-month-old Kaitlyn Pogson moved to Colorado to obtain the drug, hoping it would help with their daughter’s severe seizures.

With no medical trials showing that cannabis helps children with seizures, Arthur Schafer warned that the impact of the drug’s exposure on a child’s brain remains unknown.

“The rigorous scientific evidence isn’t there, but the anecdotal evidence seems quite promising. Would a reasonable and loving parent take the risk of giving their child medication that could cause serious harm? Not unless the situation is desperate and nothing else has worked,” said Mr. Schafer, the director of the Centre for Professional and Applied Ethics at the University of Manitoba.

“If the harm is there in front of you daily in seizures, the reasonable and loving parent might take the risk. I would.”

Follow Justin Giovannetti on Twitter: @justincgio

Source: http://m.theglobeandmail.com/news/british-columbia/toddlers-seizures-stopped-after-consuming-cannabis-oil-parents-say/article18769814/?service=mobile&cmpid=rss1&click=sf_globe

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Toddler’s seizures stopped after consuming cannabis oil, parents say

Robix Launches Corris Marine Division in Montreal and Grant of Options

Posted by AGORACOM-JC at 2:42 PM on Tuesday, May 20th, 2014

LETHBRIDGE, ALBERTA–(May 20, 2014) – Robix Alternative Fuels Inc. (“Robix” or the “Corporation”) (CSE:RZK)(FRANKFURT:R0X) announced today that it has officially launched its Corris Marine Division with the opening of its Montreal office, in the Old Port of Montreal district.

The Robix Corris Marine Division intends to own and operate shipping tankers that will transport refined oil products along established global shipping routes. In addition to producing shipping revenue, it is intended that each tanker will host a Robix Clean Ocean Vessel (“COV”), which is an oil spill recovery vessel design with the capability to recover oil in rough and debris laden sea conditions, as described below. Once installed on a tanker, the COV will be readily deployable to react to oil spills in the heavily travelled established shipping routes regionally and globally.

Robix, including its Corris Marine Division, has completed comprehensive revenue models and the financial analysis supports the creation of an initial fleet of tankers. Robix is currently in discussions with several tanker owners and the Corporation is evaluating non-dilutive financial structures to acquire these tankers.

The current plan of management of Robix contemplates the installation of a COV when commercially feasible on each tanker. The COV is an ocean vessel, catamaran-hull barge design, capable of recovering oil from water, in virtually any conditions, especially in rough seas (40 Foot COV is stable up to Beaufort 6, or 8 feet ocean waves). Contra-rotating drums lift oil/water fluid from the surface of the ocean and scavenger blades “scrape” the oil/water fluid off the drums into storage tanks within the catamaran hulls.

“Oil spills very often occur near oil pipeline port facilities where oil is off-loaded to tankers and in well-travelled oil shipping lanes, making revenue generating tankers a natural host for the COV system,” commented Nathan Hansen, President and CEO of Robix. “Our strategy is to generate revenue from the shipping of oil while being ready and able to service a global region in the event of an oil spill with a readily deployable COV system on standby. Robix has identified revenue potential from multiple sources, including shipping oil, COV standby fees as well as emergency recovery and response revenue from deployment of the COV solution.”

In addition to the launch of the Corris Marine Division, Robix wishes to announce the grant, subject to regulatory approval, of 444,000 stock options to directors and consultants at an exercise price of $0.50 per share and expire on May 21, 2017, under the Corporation’s stock option plan.

Finally, Robix will be hosting its Annual General & Special Meeting at Radisson Hotel & Conference Center, 6620-36th Street NE, Calgary, Alberta, Canada (Northeast Calgary) on May 30th, 2014. Shareholders and interested persons are invited and encouraged to attend the meeting, which will include an update from management.

About Robix:

The Corporation is an “industrial products/technology” company, offering to investors a unique opportunity to participate in a leading company in the business of ownership of patents, and their development from commercialization to worldwide expansion through various business arrangements. Robix owns a Clean Ocean Vessel (“COV”) patent, which is an oil spill recovery vessel design with the capability to recover oil in rough and debris laden sea conditions. Robix has recognized a worldwide market opportunity for effective containment, recovery and disposal equipment, particularly in the oil spill protection industry, and it proposes to develop a business model as a service provider, and/or equipment provider under licensing agreements with other industry participants, wherein Robix will use its COV patented design solution.

No stock exchange or any securities regulatory body has reviewed the contents of this news release.

This press release contains certain statements which constitute forward-looking statements or information (“forward-looking statements”), including statements regarding Robix’s business, the Corris Marine Division and the proposed transactions. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Robix’s control, including the ability of Robix to satisfy the conditions to completion of the proposed transactions, the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, environmental risks, operational risks, competition from other industry participants, the lack of availability of qualified personnel or management, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Robix believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward looking information. As such, readers are cautioned not to place undue reliance on the forward looking information, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this document are made as of the date of this document and, except as required by applicable law, Robix does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement.

Robix Alternative Fuels Inc.
Nathan Hansen
President & CEO
250-683-8957
[email protected]

Robix Alternative Fuels Inc.
Robin Ray
Chief Financial Officer
403-327-3094
[email protected]
www.robixfuels.com

Tags: , , ,
Posted in Robix Alternative Fuels | Comments Off on Robix Launches Corris Marine Division in Montreal and Grant of Options

Pot Firms Gain as CVS, Walgreen Competition a Pipe Dream

Posted by AGORACOM-JC at 2:13 PM on Tuesday, May 13th, 2014
By Shannon Pettypiece and Sonali Basak May 13, 2014 12:01 AM ET

Photographer: Kathryn Scott Osler/The Denver Post via Getty Images

Kayvan Khalatbari, has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law.

Americans seeking medical marijuana for anything from pain to seizures must turn to a patchwork of small startups for help as U.S. laws keep traditional pharmacies out of a market that may exceed $6 billion by 2019.

While more than 21 states have legalized pot for medicinal use, the drug remains illegal under federal law and banks are hesitant to accept money from its sale. That’s keeping drugstore chains CVS Caremark Corp. (CVS), Walgreen Co. and Rite Aid Corp. (RAD), out of the market, leaving local entrepreneurs in control.

“We aren’t going to see a big guy enter this market within the next few years,” said David Yang, an analyst with research firm IBISWorld. “There are just too many regulations and too many elements that make this impossible for them.”

In one state alone, Colorado, more than 400 companies are licensed as medical marijuana centers, with government officials predicting sales there could soon reach $1 billion. For Colorado businessman Kayvan Khalatbari, a former electrical engineer who started his business with just $4,000, federal limitations on the drug are a major benefit.

Khalatbari, who has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law, he said.

“We’re making money, we’re employing people, we’re being a beacon of light for this industry and showing it can be done professionally,” Khalatbari said in a telephone interview. “That to me is a success.”

Federal Law

Traditional pharmacies, meanwhile, face a hurdle that keeps them from competing with entrepreneurs like Khalatbari. Even though almost half of states and the District of Columbia accept the drug’s use for medical purposes, marijuana isn’t deemed legal by the federal government. The drug is classified as a Schedule I controlled substance, defined as having a high potential for abuse with no accepted medical use.

The Legalization of Marijuana

Schedule 1 drugs, which includes heroin, can’t by law be prescribed or dispensed. Pharmacies must register with the U.S. Drug Enforcement Agency to dispense controlled substances, making it illegal for them to sell medical marijuana.

Walgreen, Rite Aid and CVS said in separate statements they have no plans to sell medical marijuana. Doing so, according to CVS spokeswoman Carolyn Castel, would violate the company’s registration with the DEA.

Tax Revenue

That may change if the U.S. Congress sees taxes on the drug as a way to raise money, said Brad Barker, an analyst with Bloomberg Industries in New York.

“The second this is legalized they will start rolling out the marijuana cigarettes the next day,” Barker said. “I think the same thing can be said with everything else. Then you’ll have all the big boys jumping into this space.”

More pharmacies would sell medical marijuana if drug companies created cannabis products that can be approved by federal regulators, like drugs or tobacco products, said Mark Kleiman, a professor of public policy at the University of California at Los Angeles School of Public Affairs.

“It’s not drug stores that have to make these decisions, its pharmaceutical companies that have to decide if they want to make cannabis products,” Kleiman said in a telephone interview. Eventually, that could fuel a “big threat to the medical dispensary business model.”

Existing Products

Existing pharmaceutical cannabis products include Marinol, a prescription pill made with synthetic cannabinoid for uses including treating nausea associated by chemotherapy, sold by AbbVie Inc. (ABBV), and Sativex, a spray form of marijuana produced by GW Pharmaceuticals Plc (GWP), a U.K.-based medical marijuana research and development company. Sativex isn’t available in the U.S.

Shareholders are already investing in publicly traded marijuana companies like GW Pharmaceuticals and Advanced Cannabis Solutions Inc. (CANN), a company that leases growing facilities to licensed growers and dispensaries. Barker said he’s tracking 160 public marijuana companies.

American depositary receipts for GW Pharmaceuticals have increased more than sevenfold in the past 12 months to $69.77, raising the company’s market capitalization to $1.24 billion. Shares of Colorado Springs, Colorado-based Advanced Cannabis Solutions, with a market value of about $210 million, has risen more than ninefold to $15.75.

New Investors

Next Gen Metals Inc. (N), a mineral exploration company, is among the investors preparing to put private capital into marijuana startups.

“You can certainly believe the large industries, the large pharmaceutical companies, that they’re looking into it,” Jay Oness, Next Gen’s chief operating officer, said. “When the time is right, I’m positive they’ll want to be a part of it either through acquisitions or by themselves.”

Until legalization or more products are marketed by pharmaceutical companies, it will be an industry dominated by small dispensaries set up to serve about 1.4 million medical marijuana cardholders using the drug to treat their symptoms.

Three states allow medical marijuana companies to make a profit from the sale of pot. The remaining 18 states that approve of the use of medical marijuana require distribution only by nonprofit organizations and cooperatives, according to the Marijuana Policy Project.

To contact the reporters on this story: Shannon Pettypiece in New York at [email protected]; Sonali Basak in New York at [email protected]

To contact the editors responsible for this story: Reg Gale at [email protected] Andrew Pollack

Source: http://www.bloomberg.com/news/2014-05-13/pot-firms-gain-as-cvs-walgreen-competition-a-pipe-dream.html

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Pot Firms Gain as CVS, Walgreen Competition a Pipe Dream

Robix Starts Construction of its Patented Clean Ocean Vessel (COV)

Posted by AGORACOM-JC at 10:34 AM on Wednesday, May 7th, 2014

LETHBRIDGE, ALBERTA–(May 7, 2014) Robix Alternative Fuels Inc. (“Robix” or the “Corporation”) (CSE:RZX), (R0X:Frankfurt) announced today that it has recently completed the engineering drawings for the Clean Ocean Vessel (COV) and ordered critical components to initiate construction on the COV. The engineering drawings were completed by Rayco Steel Ltd, of Sparwood, BC.The highly anticipated COV is expected to be ready for commissioning in approximately four months. Robix holds a patent covering its unique COV technology.

The COV is an ocean vessel, catamaran-hull barge design, capable of recovering oil from water, in virtually any conditions, especially in rough seas (40 Foot COV is stable up to Beaufort 6, or 8 feet ocean waves). Contra-rotating drums lift oil/water fluid from the surface of the ocean and scavenger blades “scrape” the oil/water fluid off the drums into storage tanks within the catamaran hulls. A prototype of the technology has been tested, is proven and scaleable. The COV has received independent verification through a Certificate of Endorsement by COPP, the USA based Committee for Oil Pollution Prevention.

How the COV compares to the competition:

·Rates of oil recovered and recovery-throughput efficiencies are noted as “oil rate of recovery” (ORR) and “recovery efficiency” (RE).

·The water surface lifting force generated by the COV’s patented contra-rotating drums acts in a suction or pumping manner that increases the ORR compared to conventional skimmer systems and the RE of the COV is in the 90-97% range. This is competitive with best in class 21st century technology in terms of ORR and RE.

·Further improvements to the ORR (in terms of gallons per minute) could easily catapult the COV to “top three” status, by increasing the surface area of the drums through design modifications without impairing the stability of the vessel which is inherent to the COV design.

·When our competitors’ skimmer systems meet waves above 18 inches, they are forced to suspend service. The COV operates in rough sea conditions (as high as 8 feet waves), significantly out-performing its competitors, and stands in a class of its own.

“This marks the beginning of our preparation for the commercial launch of our COV product,” commented Nathan Hansen, President and CEO of Robix Alternative Fuels. “The COV’s ability to operate so efficiently even in rough water truly sets this product apart from its competition. We are in active discussions with potential strategic partners that have existing global market access, but lack a truly unique solution such as the COV, in oil spill response and recovery.”

About Robix:

The Corporation is an “industrial products/technology” company, offering to investors a unique opportunity to participate in a leading company in the business of ownership of patents, and their development from commercialization to worldwide expansion through various business arrangements.Robix owns a Clean Ocean Vessel (“COV”) patent, which is an oil spill recovery vessel design with the capability to recover oil in rough and debris laden sea conditions. Robix has recognized a worldwide market opportunity for effective containment, recovery and disposal equipment, particularly in the oil spill protection industry, and it proposes to develop a business model as a service provider, and/or equipment provider under licensing agreements with other industry participants, wherein Robix will use its COV patented design solution.

For more information please contact:

Robix Alternative Fuels Inc. Website: www.robixfuels.com

Nathan HansenorRobin Ray

President & CEOChief Financial Officer

Tel: 250-683-8957Tel: 403-327-3094

Email: [email protected] Email: [email protected]

No stock exchange or any securities regulatory body has reviewed the contents of this news release.

This news release may contain certain forward-looking information. All statements included herein, other than statements of historical fact, are forward-looking information and such information involves various risks and uncertainties. There can be no assurance that such information will prove to be accurate, and actual results and future events could differ materially from those anticipated in such information. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in the company’s disclosure documents on the SEDAR website at www.sedar.com. The company does not undertake to update any forward-looking information except in accordance with applicable securities laws.

Tags: , , , ,
Posted in Robix Alternative Fuels | Comments Off on Robix Starts Construction of its Patented Clean Ocean Vessel (COV)

Robix Announces Closing of Over-Subscribed Unit Private Placement

Posted by AGORACOM-JC at 4:12 PM on Tuesday, May 6th, 2014

Robix Alternative Fuels Inc. has increased the size of and closed its previously announced non-brokered private placement of units. Robix issued 1,775,429 units at a price of $0.33 per unit, for gross proceeds of $585,892. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder thereof to acquire one additional common share at a price of $0.45 per share for a period of two years after the closing. If, at any time, the closing price of the common shares on the Canadian Securities Exchange is at least $0.54 for a minimum of 10 consecutive trading days (whether or not trading occurs on all such days), the Corporation may, at its option, accelerate the expiry date of the warrants by giving written notice thereof to all holders of warrants, and, in such case, the warrants will expire on the date which is the earlier of: (i) the 30th day after the date on which such written notice is given by the Corporation; and (ii) the original expiry date.

Finder’s acting in connection with the private placement received aggregate fees of $44,681.93 and an aggregate amount of 135,400 finder’s warrants. Each finders warrant entitles the holder to purchase one common share at a price of $0.33 for a period of two years after the closing.

Robin Ray, the Chief Financial Officer and a director of Robix, subscribed for 90,909 units and David Edwards, a director of Robix, subscribed for 22,272 units under the private placement. Robix has determined that exemptions from the various requirements of Multilateral Instrument 61-101 are available for the issuance of the units (Formal Valuation – Issuer Not Listed on Specified Markets; Minority Approval – Fair Market Value Not More Than 25% of Market Capitalization).

All securities issued in connection with the offering are subject to a hold period that expires on September 7, 2014. The net proceeds from the offering will be used to finance the Corporation’s continuing capital program and for general working capital purposes.

We seek Safe Harbor.

Tags: ,
Posted in Robix Alternative Fuels | Comments Off on Robix Announces Closing of Over-Subscribed Unit Private Placement

St-Georges Provides Corporate Update

Posted by AGORACOM-JC at 2:45 PM on Tuesday, May 6th, 2014

 

Montreal, Quebec / May 6, 2014 / St-Georges Platinum and Base Metals Ltd. (OTCQX: SXOOF) (CSE: SX) (FSE: 85G1) would like to inform its shareholders and stakeholders about the progress of its operations. The Company would also like to inform its shareholders that it filed its annual financial statements and management’s discussion and analysis or MD&A on April 30, 2014, for the period ended December 31, 2013. The financial statements and MD&A are available on SEDAR at the address www.sedar.com under St-Georges Platinum.

Zambian Projects

The Company entered into a binding agreement to acquire two Copper-Cobalt-Gold projects in Zambia on February 5, 2014. The initial agreement called for a 90-day due diligence to expire at midnight Eastern Standard Time on May 5, 2014. Due diligence is progressing at a good pace with most of the title verification completed. Geological and Metallurgical testing will take additional time. St-Georges’ technical team has adopted a sceptical approach in reviewing the recent production data due to the high numbers and especially very high copper and cobalt grades reported to the Company by the operator on site. The Company had expected to rely on independent third party visit reports to conclude the due diligence but, in light of the current situation, management has decided to send a team on site later this month or in the early part of the month of June. Management also plans to acquire 500 metric tonnes of production mineral concentrate from the current Mwinilunga production in order to independently verify the grades and conduct metallurgical testing. Large portion of this bulk test will be conducted by AGAT Laboratories in Canada. The company also plans to hire two local mining engineers in the month of May to help with this due diligence effort. Finally, independent laboratory testing of the shipped material, and selected grab samples taken along the reef structure on Mwinilunga are expected this month and the Company will release more details about the progress of the due diligence conducted on site later this month.

The Company expects to conclude its due diligence no later than June 30, 2014 and would like to put the agreement to a shareholders vote at a Shareholders meeting as soon as the due diligence has been completed. The acquisition would be finalized right after a positive vote at the Shareholder Meeting expected in August 2014.

On May 5, 2014, the Company signed an amendment to the February 5, 2014 binding term sheet agreement that extends the due diligence period option until June 30, 2014 and the proposed closing date to no later than August 31, 2014.

Other Corporate Matters

Metallurgical Extraction Technologies Subsidiary

On December 3, 2013 the Company announced that it had entered into an option agreement with Allied Nickel in order to acquire a North American Exclusive License for Patented Technologies controlled by Allied. Lack of financial resources and time constraints caused by the acquisition of the Zambian projects limited the abilities of the Company to conduct a satisfactory due diligence on the technologies at stake. Allied informed the Company that they are willing to negotiate new terms or a new agreement with St-Georges but no details have been communicated as yet. St-Georges consider that there is no current agreement for the time being and it is evaluating other avenues to advance its intentions to build a metallurgical and processing technologies division.

Highlights from the Audited Financial Statements for the year ended December 31, 2013

  • — Total assets of the Company as at December 31, 2013 were $1,428,804 following a write down of $6,796,442 to recognize an impairment in the value of its Quebec mining exploration and evaluation assets.– Shareholders’ equity in St-Georges was $270,675 as at December 31, 2013.– As at December 31, 2013 St-Georges had negative working capital of $493,533 compared to negative working capital at December 31, 2012 of $1,672,027.

    — As at April 30, 2014, the Company had 28,448,661 common shares issued and outstanding. At the closing price of $0.125 on that date, the market capitalization of St-Georges was $3,556,083.

According to Vivian Doyle-Kelly, Chief Financial Officer of the Company, “2013 was a year of transition as St-Georges addressed its management structure and balance sheet in order to position itself to develop its strategic vision and take advantage of opportunities which it has identified”

About the Zambian Projects

The Mwinilunga Copper-Cobalt-Gold Project. Covering 740 hectares (7.4 km2) , the project is located close to the Angola and DRC borders and is in the vicinity of CopperZone and Vale Inco’s Luamata Joint-Venture Project. Current small scale punctual production of 3,000 tonnes of Copper Concentrate (15%) per month on the mining license will be consolidated under St-Georges’ control at closing of the transaction, and will be managed under a service agreement to be finalized before the end of the due diligence period.

The Shongwa IOCG & Nickel Project. Covers an area of 72,600 hectares (726 Km2) and is located approximately 60 km northwest of the town of Kasempa. There is a current JORC Definitive Feasibility Study (DFS) in place and the Company plans to verify and integrate the historical and JORC information into new NI 43-101 reports, and is currently evaluating the level of work required. The Company further expects to initiate work on a NI 43-101 compliant Preliminary Economic Assessment Study (PEA) later in 2014 or early 2015, conditional to the closing of the acquisition transaction.

Mr. Joel Scodnick, P.Geo. St-Georges’ Vice-President Exploration is a Qualified Person as defined by NI 43-101 and has reviewed and verified the scientific and technical mining disclosure contained in this news release.

ON BEHALF OF THE BOARD OF DIRECTORS

Frank Dumas

Director & Executive Chairman

About St-Georges

St-Georges is a vertically integrated Platinum-Palladium-Gold, Copper-Cobalt & Nickel Explorer and Developer. Headquartered in Montreal, the Company’s stock is listed on the CSE under the symbol SX, on the OTCQX under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1. For additional information, please visit our website at www.stgeorgesplatinum.com

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: , , , , , ,
Posted in St. Georges Platinum and Base Metals | Comments Off on St-Georges Provides Corporate Update

Next Gen Establishes its Second 100% owned Subsidiary, GreenRush Analytical Laboratories Inc.

Posted by AGORACOM-JC at 8:37 AM on Tuesday, May 6th, 2014

-GreenRush Analytical Labs (GAL) is a wholly owned Subsidiary of Next Gen

-The Mission of GreenRush Analytical Labs; is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.

-The Vision of GreenRush Analytical Labs; is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.

-Proposed new Canadian Medical Marijuana and Industrial Hemp laws and regulations are anticipated to set additional standards for licensed producers that require more detailed Quality control and Quality assurances from Licensed Producers.

-Anticipated new legislation in the United States for medical/recreational Marijuana and Industrial Hemp can derive unprecedented growth in these new Multi-Billion Dollars industries

Vancouver, British Columbia, Canada-(May 6th, 2014) – Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that it has established its second %100 owned subsidiary, GreenRush Analytical Laboratories Inc. (GAL). The Mission of GreenRush Analytical Laboratories Inc. is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.
Next Gen’s competitive advantages include:

  1. 1.Management’s financial contacts to raise venture capital
  2. 2.Management’s ability to efficiently manage both public and private companies on an

International scale

  1. 3.Management’s ability to negotiate equitable deals for our shareholders and partners
  2. 4.Management’s ability to Complete its objectives on time and on budget

GAL is organizing a team of scientists and laboratory technicians to staff our first Laboratory. Simultaneously GAL’s management continues to meet with targeted under-funded Analytical Laboratory opportunities for possible mergers and acquisitions.

With over 300 years of experience and managing public and private companies, negotiating complex deals and raising venture capital our Management team has completed over 300 option/joint venture agreements with major, mid-tier and junior companies and have raised over $250,000,000 in equity to advance projects across the world.

Harry Barr, President and CEO stated, “New laws and legislations in Canada and in the United States allow production of Legal/Medical Marijuana. An increasing number of U.S states have allowed Licensed Producers, to produce Medical Marijuana. Additionally, to date, two States have legalized Recreational Marijuana.

In Canada; new federal laws (April 1st 2014) allowed for Licensed Producers to establish new legal Marijuana grow up operations to produce Marijuana. To that end ,and as of today, there are currently thirteen Licensed Producers in Canada and over 650 applications in progress1.

This unpredicted growth in this new multi-billion dollars industry has allowed the directors and management of Next Gen to provide an increasing number of financial solutions for the Medical Marijuana and Industrial Hemp industries.”

Management is currently in the process of assessing and selecting initial locations and jurisdictions to establish the laboratories. Management’s objective is to initiate analytical laboratories in areas with the greatest concentration of Licensed Producers in both the legal Medical Marijuana and Industrial Hemp industries.

Market Demand

Under the new MMPR program, companies that wish to grow and sell medical marijuana must follow a strict set of rules, including quality control and data keeping protocols.

For example, each batch of cannabis must be tested for pesticides, mold and contaminants, in addition to chemical composition, before being sold2.

New standards for quality control and quality assurance in the USA and in Canada are deriving increased demand for these analytical tests and procedures. Three main purposes for Medical Cannabis and Industrial

Hemp testing are:

  1. 1.Health Canada requirements
  2. 2.Patient and consumer safety
  3. 3.Limiting liability for Licensed Producers

Market Size
Health Canada estimates that the market could be worth $1.3 billion by 2024. Analysts and industry experts peg estimates to be closer to $2.6 billion by 2016.

The medical community, health givers and patients demanding product testing to understand the safety and the strength of a particular product, and find the best medicine to alleviate their particular ailments.

In light of Next Gen’s vision and having completed our first two investments, Management’s objective is to invest in a basket of company’s within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.

About GreenRush Financial Conferences

GreenRush Conferences shares a similar vision as its sole shareholder Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN): a vision to provide a forum for venture capital investment, education, business to business opportunities as well as act as a facilitator for this emerging industry.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

The first conference will held in Vancouver, British Columbia on Wednesday May 7th, 2014 at the Vancouver Convention and Exhibition Centre East, Ballrooms A/B/C in the Pan Pacific Hotel. The company is planning a second conference to be held in Toronto, Conference Centre, Ontario on June 26th, 2014 at Toronto’s Conference Centre. Further conferences are also slated for other cities in Canada and the United States and Europe.

For more information on GreenRush Conferences please visit our website at www.greenrushfinancialconferences.com, email us at [email protected] or contact us by phone at (604) 685-1870.
About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry.
Next Gen’s vision is to be the leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry.

Our business model generates dozens of new business plans and industry related proposals on an ongoing basis. Management continues to receive and review the proposals from various segments of the industry including: alternative medicine, health, food, agri-business, legal grow-ops, technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. For further information, visit our website at www.nextgenmetalsinc.com.

On March 20, 2014, Next Gen Metals announce that it has established its first wholly owned subsidiary, a Conference Division, that intends to host Canada’s first conferences focused on business to business opportunities, investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

On May 6th, 2014 Next Gen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories Inc. would be dedicated to helping physicians and health care providers improve patient health.

In light of Next Gen’s vision, Management’s intention is to invest in a basket of companies within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.
For further information on GreenRush Analytical Laboratories Inc. please visit us at www.nextgenmetalsinc.com

On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this News Release

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , ,
Posted in Medical Marijuana Stocks, Next Gen | Comments Off on Next Gen Establishes its Second 100% owned Subsidiary, GreenRush Analytical Laboratories Inc.

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

Posted by AGORACOM-JC at 10:58 AM on Monday, May 5th, 2014

Next Gen Subsidiary Announces First of Global Series of Industry, Finance and Investment Conferences

VANCOUVER,B.C., May 5, 2014 (GLOBE NEWSWIRE) — A hundred and fifty years ago, Harry Barr’s (President and CEO of Next Gen Metals) (CSE:N) (OTC Pink:NXTTF), ancestors began farming in the Ottawa Valley. As far back as pre WWII, the family farm was producing hemp, which in those days was used primarily for rope for the War Act.

At 23, a young Harry Barr graduated from the University of Guelph in Agribusiness and began a career that forged him into a global mining executive and financier. Barr notes that since 1985, every exploration company he has started is still in business today and managed from Vancouver.

Now, Barr’s company has seized the opportunity to incubate and mentor those legal marijuana and hemp companies that have the technical savvy, but require the business acumen that any new or expanding industry needs; be it fundraising, complex negotiation skills, capital markets expertise, public company administration or IPO’s.

Those tenets will take shape in a big way on May 7th, when Next Gen’s 100 percent-owned subsidiary, GreenRush Financial Conferences launches in Vancouver at the Convention Centre East and the Pan Pacific Hotel with the first of a series of global Medical Marijuana and Industrial Hemp conferences, bringing together stakeholders, investors, companies and the legal community. Simply put, these conferences intend to be the premier purveyor of investment education and finance for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

“I applaud Mr. Barr for being a pioneer and recognizing the lack of Marijuana expositions in Canada that focus on finance,” stated Mike Withrow, President and CEO of Abattis Bioceuticals Corp (OTC PINK:ATTBF). “We now have a forum to tell the world about our Grow Dry Extract Refine and Sciences model coined GDERS.”

“The Medical Marijuana business is slowly recapitalizing the junior mining industry in Canada,” stated Harry Barr, CEO of Next Gen. “But more than that, it is quickly bringing together the legal and industry forces necessary to give a complex, highly regulated market the visibility and transparency that investors require.”

Barr’s quote that the Medical Marijuana Industry is recapitalizing junior mining is a result of the fact that Canadian Securities Laws have allowed for thousands of Venture Capital companies to be formed. Given the mining downturn of the last three years, many of these entrepreneurs with proven fund raising and capital market abilities are now taking their shareholders into this new multibillion-dollar industry.

As well as discussing direct investment opportunities, the GreenRush Conferences will focus on the latest Medical Marijuana research, legal issues and give an overview of the industrial hemp market and the role of Alternative Medicines.

There is little chance that growth in this space will retreat anytime soon. The majority of support for the legalization exceeds 50% in Boomers and hits 65% for Millennials. From 1969 to 2013, legalization of marijuana supporters grew from 12% to 52%. Those wanting it to remain illegal dropped from 84% to 45% in the same period.

Barr was an early adopter who, using mining parlance, staked his claim in the Medical Marijuana space well before most others. Unlike some juniors, from Day One, his approach was not knee-jerk opportunism, but a well thought out business strategy utilizing decades of business acumen to add consistent shareholder value.

Management of Next Gen (as well as other entrepreneurs) is very good at raising capital. The Company intends to extend its brand to this industry and is actively seeking and reviewing new business plans. It intends to be a leader in the space and the go-to Company for legal marijuana and industrial hemp investments.

Barr is also the driving force of the International Metals Group (IMG), a brain bank of project acquisition, exploration and development professionals, including dedicated CEOs, geologists, engineers, corporate finance and investor relations experts, corporate managers, public company administrators, and regulatory and government affairs specialists.

To date, IMG companies (past and present) have completed over 300 option/joint venture agreements with major, mid-tier and junior companies and raised over $250,000,000 to advance their projects throughout 9 countries.

Barr could well be right in his assumptions, being a fixture on the mining scene for 29 years. As CEO, Chairman and Director of Pacific North West Capital Corp, he is also Chairman and CEO of El Nino Ventures, President of Next Gen Minerals (CSE:N) (OTC Pink: NXTTF) and Chairman of Southern Sun Minerals. Pacific North West Capital Corp is a controlling shareholder of Next Gen (22%), approximately 10% of El Nino Ventures and has a modest but important stake in Southern Sun Minerals.

Barr is not abandoning his mining roots and projects. In Ontario, Barr’s Pacific Northwest Capital made a grass roots discovery on its River Valley Platinum Group metal property, which is now a multi-million ounce deposit. The Group’s mining team is working hard to joint venture this advanced stage project with a company capable of financing this project to production.

As well, in Bathurst, New Brunswick, Mr. Barr’s El Nino Venture’s has two option agreements with Glencore Canada and Brazil’s second largest mining company Votorantim. Earlier this year El Nino won a five-year international arbitration on its D.R.C. copper discovery freeing up this project for continued development.

The GreenRush Financial Conference Exhibitor Space opens at 7:00 am; the opening talk is at 8:00am and concludes at 6:pm on May 7th at the Vancouver Convention Centre East and Ballrooms A/B/C/ in the Pan Pacific Hotel. The final hour hosts a discussion entitled; “The Great Debate: Legalization versus Prohibition,” followed by drinks and informal networking and discussion.

As well as an impressive lineup of speakers, there is an exhibitor hall with representatives from the Medical Marijuana community, investment dealers, financial professionals, media and the legal profession. Investors, media and other interested individuals can register through the conference site at www.greenrushfinancialconferences.com.

Of the more than two-dozen speakers are Bruce Linton from Tweed Marijuana (TSX-V:TWD), Harry Barr from Next Gen Metals, Chris Bunka from Lexaria Corp (OTCQB:LXRP), Craig Goodwin of Naturally Splendid (TSX-V:NSP), John Conroy of Conroy & Company and Daniel L. Kiselbach from Deloitte.

While the Medical Marijuana market represents a unique investment opportunity, it is important for investors to arm themselves with the facts in this complex, burgeoning market. Highly regulated, the companies that do the stringent due diligence necessary and develop the most growth-oriented alliances and partnerships will undoubtedly be the names that rise to the top as the space matures and garners increasing investor interest.                                                                                                                             

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author’s only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

CONTACT: 650 - 555 West 12th Avenue, City Square, West Tower
         Vancouver, B.C. V5Z 3X7 Canada
         Telephone: 604.685.1870 Facsimile: 604.685.8045
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana 
Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , ,
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

Lexaria Appoints Former Chief of Police as Security Consultant

Posted by AGORACOM-JC at 8:20 AM on Monday, May 5th, 2014

Kelowna, British Columbia–(May 5, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce the appointment of the Security Consultant for the new Ontario production facility.

The former Chief of Police of the Hamilton Police Service has become Security Advisor to the Lexaria/Enertopia joint venture. Mr. Brian Mullan will provide advice to the Board of Directors and to management on the safe production, storage, and shipment of controlled substances; as well as provide and manage security protocols and procedures consistent with the needs of a medical marijuana facility and its staff.

Brian was a career police officer who retired as the Chief of Hamilton Police Service in December 2009 after having been a member for over 35 years He is the President of Bmullan and Associates. Brian has received the Police Exemplary Service Medal and he has been appointed as a Member of the Order of Merit for Police. Brian has a Bachelors Degree in Business Administration. He is a graduate of the F.B.I. Academy in Quantico Virginia and the F.B.I’s prestigious National Executive Institute. Brian has also attended the University of Toronto’s Rotman School of Business, Mohawk College and Bay Area Leadership Program and has been active in his community.

“The Lexaria/Enertopia joint venture team has sufficient expertise and ability to operate our planned world-class production facility,” said Chris Bunka, CEO of Lexaria. “I personally welcome Mr. Mullan and all the other experts who have recently joined us, and applaud their shared vision in coming together to build one of the largest and most secure regulated marijuana production facilities in the world.”

Mr. Mullan is eligible to receive up to 275,000 restricted common shares of stock over time in his role as a Lexaria consultant, depending on certain specified performance thresholds being reached.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Manager: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business or any member of the management team or consultant will provide any benefit to Lexaria.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp., McLaren Resources | Comments Off on Lexaria Appoints Former Chief of Police as Security Consultant

Enertopia Announces Former Chief of Police as Security Consultant

Posted by AGORACOM-JC at 8:00 AM on Monday, May 5th, 2014

Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce additional member to the Company and for the new Ontario marihuana production facility.

The former Chief of Police of the Hamilton Police Service has become Security Advisor to the Enertopia/Lexaria joint venture. Mr. Brian Mullan will provide advice to the Board of Directors and to management on the safe production, storage, and shipment of controlled substances; as well as provide and manage security protocols and procedures consistent with the needs of a medical marijuana facility and its staff.

Brian was a career police officer who retired as the Chief of Hamilton Police Service in December 2009 after having been a member for over 35 years.  He is the President of Bmullan and Associates.  Brian has received the Police Exemplary Service Medal and he has been appointed as a Member of the Order of Merit for Police.  Brian has a Bachelors Degree in Business Administration.  He is a graduate of the F.B.I. Academy in Quantico Virginia and the F.B.I’s prestigious National Executive Institute.  Brian has also attended the University of Toronto’s Rotman School of Business, Mohawk College and Bay Area Leadership Program, and he has been active in his community.

“I welcome Mr. Mullan to our joint venture team that we continue to assemble with the expertise and ability to operate our planned top tier production facility, that is focused on building one of the largest and most secure regulated marijuana production facilities in Canada” said Robert McAllister, President CEO of Enertopia

Mr. Mullan is eligible to receive up to 225,000 restricted common shares of stock, over time in his respective role as Security Consultant, depending on certain specified performance thresholds being reached.

 

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP in the United States with symbol ENRT. For additional information on this press release, please visit www.enertopia.com or call Clark Kent at 1.647.519.2646 or President Robert McAllister at 250.765.6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, evaluation of clean energy projects, Oil & Gas Projects, Medical Marihuana Projects  for participation and/or financing, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements.  Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that the Company will be successful in completing any anticipated financing and or its joint Venture partners will receive their Health Canada license under the new regulations or any will future sales will result or any consultant will have a material impact on the Company.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

 Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in All Recent Posts, Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Announces Former Chief of Police as Security Consultant

« Older Entries
Newer Entries »